Evidence map›Paper›PMID 37920264›Full record

ArticleFrontiers in microbiology2023

Biotic countermeasures that rescue

Brittany Humphrey, Morgan Mackenzie, Mia Lobitz, Jenna Y Schambach, Greyson Lasley, Stephanie Kolker, Bryce Ricken, Haley Bennett, Kelly P Williams, Chuck R Smallwood and 1 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Brittany Humphrey *Sandia National Laboratories, Department of Molecular and Microbiology, Albuquerque, NM, United States.
Morgan Mackenzie *Sandia National Laboratories, Department of Molecular and Microbiology, Albuquerque, NM, United States.
Mia LobitzSandia National Laboratories, Department of Molecular and Microbiology, Albuquerque, NM, United States.
Jenna Y SchambachSandia National Laboratories, Department of Molecular and Microbiology, Albuquerque, NM, United States.
Greyson LasleySandia National Laboratories, Department of Molecular and Microbiology, Albuquerque, NM, United States.
Stephanie KolkerSandia National Laboratories, Department of Molecular and Microbiology, Albuquerque, NM, United States.
Bryce RickenSandia National Laboratories, Department of Molecular and Microbiology, Albuquerque, NM, United States.
Haley BennettSandia National Laboratories, Department of Molecular and Microbiology, Albuquerque, NM, United States.
Kelly P WilliamsSandia National Laboratories, Department of Systems Biology, Livermore, CA, United States.
Chuck R SmallwoodSandia National Laboratories, Department of Molecular and Microbiology, Albuquerque, NM, United States.
Jesse CahillSandia National Laboratories, Department of Molecular and Microbiology, Albuquerque, NM, United States.
Sandia National Laboratories · USSandia National Laboratories California · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The natural assemblage of a symbiotic bacterial microbiome (bacteriome) with microalgae in marine ecosystems is now being investigated as a means to increase algal productivity for industry. When algae are grown in open pond settings, biological contamination causes an estimated 30% loss of the algal crop. Therefore, new crop protection strategies that do not disrupt the native algal bacteriome are needed to produce reliable, high-yield algal biomass. Bacteriophages offer an unexplored solution to treat bacterial pathogenicity in algal cultures because they can eliminate a single species without affecting the bacteriome. To address this, we identified a highly virulent pathogen of the microalga

Indexed as

crop protectionmicroalgaemicrobiomephage therapytransplant

Identifiers

PMID37920264
PMCPMC10618357
OpenAlexW4387740546

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.